• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Nerve Regeneration Market Analysis

    ID: MRFR/Pharma/0696-CR
    145 Pages
    Kinjoll Dey
    August 2019

    Nerve Regeneration Market Research Report Information By Product (Neurostimulation & Neuromodulation Devices, Biomaterials), By Application (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Nerve Regeneration Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Nerve Regeneration Market Industry Landscape

    Venturing into developing economies represents a significant opportunity for various markets, particularly those that address health challenges. These economies often have underdeveloped research and development sectors, limiting their capacity to tackle emerging health issues effectively. In regions like Africa, despite a substantial demand for healthcare solutions, there is a reliance on imported medicines and other health technologies due to the sluggish growth of the healthcare industry. The economic challenges prevalent in these areas hinder the development of robust healthcare infrastructure. According to the World Health Organization (WHO) statistics from 2017, a noteworthy 80% of the population affected by epilepsy resided in low- and middle-income countries. Similarly, Alzheimer's Research UK reported that 58% of all individuals with dementia were located in lower-middle-income countries, a percentage expected to climb to 68% by 2050. The prevalence of neurological disorders in developing countries, coupled with the vast untreated population, presents a substantial opportunity for the nerve regeneration market. In developing economies, the healthcare landscape faces unique challenges characterized by limited resources, infrastructure gaps, and economic constraints. Despite the high demand for treatments, the slow growth of the healthcare sector in these regions underscores the need for innovative solutions to address prevalent health issues effectively. Neurological disorders, in particular, pose a significant burden on the population, and the existing treatment gaps offer a compelling opportunity for the nerve regeneration market to make a meaningful impact. The underserved populations in developing economies create a niche for market players to introduce cutting-edge nerve regeneration technologies and therapies. By addressing the unmet healthcare needs in these regions, companies can contribute to improving health outcomes and enhancing the overall quality of life for individuals grappling with neurological disorders. The demand for innovative and accessible healthcare solutions in developing economies provides a strategic entry point for the nerve regeneration market to expand its reach and make a positive societal impact. As the global healthcare landscape evolves, there is a growing recognition of the importance of inclusive and equitable healthcare access. The potential for market growth in developing economies lies not only in addressing the existing treatment gaps but also in fostering long-term partnerships and collaborations that contribute to building sustainable healthcare infrastructure. By aligning with the unique needs and challenges of developing economies, the nerve regeneration market can position itself as a key player in advancing healthcare solutions on a global scale. In conclusion, the exploration of developing economies represents a promising avenue for the nerve regeneration market. The prevalence of neurological disorders, coupled with the underserved healthcare landscape, creates a conducive environment for market expansion. By introducing tailored solutions, fostering collaborations, and addressing the specific healthcare challenges in these regions, the nerve regeneration market can play a pivotal role in transforming healthcare outcomes and making a positive difference in the lives of individuals in developing economies.

    Market Summary

    The Global Nerve Regeneration Market is projected to grow from 11.3 USD Billion in 2024 to 36.69 USD Billion by 2035, reflecting a robust CAGR of 11.32%.

    Key Market Trends & Highlights

    Nerve Regeneration Key Trends and Highlights

    • The market is expected to expand significantly, reaching 36.7 USD Billion by 2035.
    • From 2025 to 2034, the market is anticipated to grow at a CAGR of 11.32%.
    • In 2024, the market valuation stands at 11.3 USD Billion, indicating a strong growth trajectory.
    • Growing adoption of advanced nerve regeneration technologies due to increasing prevalence of neurological disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 11.28 (USD Billion)
    2035 Market Size 36.69 (USD Billion)
    CAGR (2025-2035) 11.32%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    GiMer Medical, Medtronic PLC, Abbott Laboratories, Collagen Matrix, NeuroSigma, Boston Scientific Corporation, Intergra LifeSciences, Nerve Corp, NeuroPace, AxoGen, KeriMedical, Polyganics, Synapse Biomedical

    Market Trends

    Growing prevalence of neurological and epidemiological problems to drive the market growth

    An increase in the prevalence of neurological and epidemiological problems is one of the main factors influencing the market for nerve repair and regeneration. Research in the July 2021 issue of The

    Lancet

    Global Health stated that there are approximately 50 million epileptics worldwide. In India, approximately 10–12 million people have been diagnosed with

    epilepsy Figure 1: Neurological disorders as percentage of total DALYs for 2005, 2015 and 2030 across World Bank

     

    income category Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Additionally, the availability of numerous medicines for managing different Central Nervous System (CNS) illnesses, including Parkinson's disease and Alzheimer's, and the expanding range of applications, are projected to support the market expansion over the coming years. The Alzheimer's Association estimates that 6.5 million Americans aged 65 or older will have Alzheimer's disease in 2022. Thus, it is anticipated that this aspect will accelerate nerve regeneration market revenue globally.

    The Global Nerve Regeneration Market is poised for transformative growth, driven by advancements in biomaterials and regenerative medicine that enhance recovery outcomes for patients with nerve injuries.

    U.S. National Institutes of Health

    Nerve Regeneration Market Market Drivers

    Market Trends and Projections

    The Global Nerve Regeneration Market Industry is poised for substantial growth, with projections indicating a market value of 11.3 USD Billion in 2024 and an anticipated increase to 36.7 USD Billion by 2035. The compound annual growth rate of 11.32% from 2025 to 2035 underscores the robust demand for nerve regeneration therapies. Key trends influencing this growth include advancements in technology, increasing incidences of neurological disorders, and supportive government policies. These factors collectively contribute to a dynamic market environment, fostering innovation and enhancing treatment options for patients worldwide.

    Increasing Geriatric Population

    The aging population is a critical driver of the Global Nerve Regeneration Market Industry. As individuals age, the likelihood of experiencing nerve-related issues increases, leading to a greater demand for nerve regeneration therapies. The United Nations projects that the global population aged 60 and over will reach 2.1 billion by 2050. This demographic shift necessitates the development of effective treatment options for age-related neurological conditions, thereby stimulating market growth. The anticipated compound annual growth rate of 11.32% from 2025 to 2035 reflects the increasing need for innovative solutions tailored to this population.

    Government Initiatives and Funding

    Government initiatives aimed at enhancing healthcare infrastructure and funding research in nerve regeneration are significantly influencing the Global Nerve Regeneration Market Industry. Various countries are allocating resources to support clinical trials and research projects focused on nerve repair and regeneration. For example, the National Institutes of Health in the United States has increased funding for studies related to nerve injuries and regeneration. Such initiatives not only foster innovation but also encourage collaboration between academic institutions and industry players, ultimately leading to the development of new therapies and technologies that address unmet medical needs.

    Growing Awareness and Patient Advocacy

    The Global Nerve Regeneration Market Industry is benefiting from increased awareness and advocacy surrounding neurological health. Patient advocacy groups are playing a pivotal role in educating the public about nerve injuries and the importance of timely treatment. This heightened awareness is leading to more individuals seeking medical attention for nerve-related issues, thereby driving demand for regenerative therapies. Moreover, campaigns aimed at reducing stigma associated with neurological disorders encourage patients to explore available treatment options. As awareness continues to grow, the market is likely to expand, reflecting the evolving landscape of patient care.

    Rising Incidence of Neurological Disorders

    The Global Nerve Regeneration Market Industry is experiencing growth due to the increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. According to the World Health Organization, neurological disorders affect millions globally, leading to a heightened demand for effective treatment options. This surge in patient population necessitates advancements in nerve regeneration technologies, which are projected to reach a market value of 11.3 USD Billion in 2024. As awareness of these conditions grows, healthcare providers are likely to invest more in innovative therapies, thereby driving the market further.

    Technological Advancements in Regenerative Medicine

    Technological innovations in regenerative medicine are propelling the Global Nerve Regeneration Market Industry forward. Breakthroughs in stem cell therapy, bioengineering, and nerve grafting techniques have shown promising results in restoring nerve function. For instance, the development of 3D bioprinting has enabled the creation of nerve conduits that mimic natural nerve structures. These advancements not only enhance treatment efficacy but also attract significant investments from both public and private sectors. As these technologies continue to evolve, the market is expected to grow substantially, with projections indicating a value of 36.7 USD Billion by 2035.

    Market Segment Insights

    Nerve Regeneration Product Insights

    The Market segments of Nerve Regeneration, based on product, includes

    & neuromodulation devices, and biomaterials. The neurostimulation & neuromodulation devices segment held the majority share in 2022 in the Nerve Regeneration Market revenue. In the upcoming years, market growth is projected to be fueled by investments made by major corporations in creating more efficient gadgets. For instance, Boston Scientific's Precision Montage MRI Spinal Cord Stimulator System obtained FDA approval in May 2016. According to the business, this technology reduces discomfort by 70% more.

    Nerve Regeneration Application Insights

    The Nerve Regeneration Market segmentation, based on application, includes neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. The neurostimulation and neuromodulation surgeries segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The market is expected to increase due to numerous government initiatives and approvals to perform clinical studies of biomaterials, the neurostimulation and neuromodulation surgeries sector is anticipated to have the highest CAGR during the expected period and drive the market of nerve regeneration.

    Nerve Regeneration End-User Insights

    The Nerve Regeneration Market data, based on end-user, includes hospitals & clinics, ambulatory surgery centers. The hospitals & clinics segment dominated the market revenue of nerve regeneration in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The hospital & clinics held the largest share in this segment as hospitals & clinics are much more accessible by the common public to treat neural disorders.

    It is even more prevalent in the US, as they lack a robust national healthcare system, and citizens are forced to visit hospitals & clinics that are covered by their health insurance provider.

    Get more detailed insights about Nerve Regeneration Market Research Report - Forecast till 2034

    Regional Insights

    Key Companies in the Nerve Regeneration Market market include

    Industry Developments

    April 2022: 

    Boston Scientific got FDA approval for Vercise Neural Navigator with Stimview XT, its image-guided software, in 2022 for deep brain stimulation therapy in Parkinson's patients.

    January 2022: 

    For the treatment of chronic pain brought on by diabetic peripheral neuropathy, Medtronic acquired FDA approval for the Intellis neurostimulator and the Vanta neurostimulator in 2022. (DPN).

    November 2021: 

    A collaboration agreement was formed in 2021 by Neuronetics, Inc. and River Region Psychiatry Associates (RRPA), one of the top US mental health service providers. According to the deal, Neuronetics would supply RRPA and its clinics with transcranial magnetic stimulation (TMS) equipment exclusively.

    January 2020: 

    A privately held US business called Stimgenics, LLC was purchased by Medtronic plc in 2020. This acquisition would strengthen the portfolio of spinal cord stimulation solutions offered by Medtronic.

    Future Outlook

    Nerve Regeneration Market Future Outlook

    The Nerve Regeneration Market is projected to grow at 11.32% CAGR from 2024 to 2034, driven by advancements in biomaterials, increasing prevalence of neurological disorders, and rising investments in regenerative medicine.

    New opportunities lie in:

    • Develop innovative biomaterials for nerve repair applications.
    • Expand telemedicine platforms for remote rehabilitation services.
    • Invest in R&D for neuroprotective therapies targeting specific nerve injuries.

    By 2035, the Nerve Regeneration Market is expected to achieve substantial growth, reflecting advancements in treatment methodologies and increased patient access.

    Market Segmentation

    Nerve Regeneration Product Outlook

    • Neurostimulation & Neuromodulation Devices
    • Biomaterials

    Nerve Regeneration End User Outlook

    • Hospitals & Clinics
    • Ambulatory Surgery Centers

    Nerve Regeneration Regional Outlook

    North America
    • US
    • Canada

    Nerve Regeneration Application Outlook

    • Neurostimulation and Neuromodulation Surgeries
    • Direct Nerve Repair/Neurorrhaphy
    • Nerve Grafting
    • Stem Cell Therapy

    Report Scope

    Attribute/Metric Details
    Market Size 2024   11.28 (USD Billion)
    Market Size 2025   12.55 (USD Billion)
    Market Size 2034   32.96 (USD Billion)
    Compound Annual Growth Rate (CAGR)   11.32 % (2025 - 2034)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2034
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Application, End-User and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled GiMer Medical, Medtronic PLC, Abbott Laboratories, Collagen Matrix, NeuroSigma, Boston Scientific Corporation, Intergra LifeSciences
    Key Market Opportunities Development in nerve regeneration technology
    Key Market Dynamics Prevalence of neural disorders

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    [email protected]

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    [email protected]

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    How much is the Nerve Regeneration market?

    The Nerve Regeneration Market size was valued at USD 11.28 billion in 2024.

    What is the growth rate of the Nerve Regeneration market?

    The global market is projected to grow at a CAGR of 11.32 % during the forecast period, 2025 - 2034

    Which region held the largest market share in the Nerve Regeneration market?

    North America had the largest share in the global market

    Who are the key players in the Nerve Regeneration market?

    The key players in the market are GiMer Medical, Medtronic PLC, Abbott Laboratories, Collagen Matrix, NeuroSigma, Boston Scientific Corporation, Intergra LifeSciences

    Which product led the Nerve Regeneration market?

    The neurostimulation & neuromodulation devices category dominated the market in 2022.

    Which end-user had the largest market share in the nerve regeneration market?

    The hospitals & clinics had the largest share in the global market.

    1. Market Introduction
      1. Definition 17
      2. Scope of the Study 17
      3. Market Structure 17
    2. Research Methodology
      1. Research Process 18
      2. Primary Research 19
      3. Secondary Research 20
      4. Market Size Estimation 21
      5. Forecast Model 21
    3. Market Dynamics
      1. Introduction 22
      2. Drivers 23
        1. Rising Neurological Disorders 23
        2. Increasing Geriatric Population 23
        3. Technological Advancements 23
      3. Restraints 24
        1. Stringent Regulatory Framework 24
        2. High Cost 24
      4. Opportunity 24
        1. Entering Developing Economies 24
    4. Market Factor Analysis
      1. Value Chain Analysis 25
        1. Research and Development 25
        2. Manufacturing 25
        3. Distribution & Sales 26
        4. Post-Sales Monitoring 26
      2. Porter’s Five Forces Model 27
        1. Threat of New Entrants 27
        2. Bargaining Power of Suppliers 27
        3. Bargaining Power of Buyers 28
        4. Threat of Substitutes 28
        5. Intensity of Rivalry 28
      3. Pricing Analysis 29
    5. Global Nerve Regeneration Market, by Product
      1. Introduction 30
      2. Neurostimulation and Neuromodulation Devices 32
        1. Internal Neurostimulation Devices 33
        2. External Neurostimulation Devices 34
      3. Biomaterials 35
    6. Global Nerve Regeneration Market, by Application
      1. Introduction 37
      2. Neurostimulation and Neuromodulation Surgeries 39
      3. Direct Nerve Repair/Neurorrhaphy 41
      4. Nerve Grafting 42
      5. Stem Cell Therapy 43
    7. Global Nerve Regeneration Market, by End User
      1. Introduction 44
      2. Hospitals and Clinics 45
      3. Ambulatory Surgery Centers 46
    8. Global Nerve Regeneration Market, by Region
      1. Overview 47
      2. Americas 48
        1. North America 53
        2. South America 67
      3. Europe 72
        1. Western Europe 77
        2. Eastern Europe 109
      4. ASIA–PACIFIC 114
        1. China 119
        2. Japan 124
        3. India 128
        4. South Korea 133
        5. Australia 137
        6. Rest of Asia-Pacific 142
      5. Middle East & Africa 147
        1. Middle East 152
        2. Africa 157
    9. Company Landscape
      1. Company Share Analysis 162
    10. Company Profile
      1. Boston Scientific Corporation 164
        1. Company Overview 164
        2. Financial Overview 164
        3. Products/Services Offered 165
        4. Key Developments 165
        5. SWOT Analysis 166
        6. Key Strategies 166
      2. LivaNova PLC 167
        1. Company Overview 167
        2. Financial Overview 167
        3. Products/Services Offered 168
        4. Key Developments 168
        5. SWOT Analysis 168
        6. Key Strategies 168
      3. Axogen Corporation 169
        1. Company Overview 169
        2. Financial Overview 169
        3. Products/Services Offered 169
        4. Key Developments 170
        5. SWOT Analysis 170
        6. Key Strategies 170
    11.  
      1. Integra LifeSciences 171
        1. Company Overview 171
        2. Financial Overview 171
        3. Products/Services Offered 172
        4. Key Developments 173
        5. SWOT Analysis 173
        6. Key Strategies 173
      2. Abbott 174
        1. Company Overview 174
        2. Financial Overview 174
        3. Products/Services Offered 175
        4. Key Developments 175
        5. SWOT Analysis 175
        6. Key Strategies 176
      3. Stryker Corporation 177
        1. Company Overview 177
        2. Financial Overview 177
        3. Products/Services Offered 178
        4. Key Developments 178
        5. SWOT Analysis 178
        6. Key Strategies 179
      4. Nuvectra Corporation 180
        1. Company Overview 180
        2. Financial Overview 180
        3. Products/Services Offered 180
        4. Key Developments 181
        5. SWOT Analysis 181
        6. Key Strategies 181
      5. NeuroPace 182
        1. Company Overview 182
        2. Financial Overview 182
        3. Products/Services Offered 182
        4. Key Developments 182
        5. SWOT Analysis 183
        6. Key Strategies 183
      6. Polyganics 184
        1. Company Overview 184
        2. Financial Overview 184
        3. Products/Services Offered 184
        4. Key Developments 184
        5. SWOT Analysis 185
        6. Key Strategies 185
      7. Medtronic 186
        1. Company Overview 186
        2. Financial Overview 186
        3. Products/Services Offered 187
        4. Key Developments 187
        5. SWOT Analysis 188
        6. Key Strategies 188
    12. Appendix
      1. References 189
      2. Related Reports 189
    13. List of Tables and Figures
      1. 12 List of Tables
      2. TABLE 1 GLOBALNERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 31
      3. TABLE 2 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 32
      4. TABLE 3 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY REGION, 2023–2030 (USD MILLION) 32
      5. TABLE 4 GLOBAL NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 33
      6. TABLE 5 GLOBAL NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 34
      7. TABLE 6 GLOBAL NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 35
      8. TABLE 7 GLOBAL NERVE REGENERATION MARKET FOR BIOMATERIALS, BY REGION, 2023–2030 (USD MILLION) 36
      9. TABLE 8 GLOBAL NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 38
      10. TABLE 9 GLOBAL NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 39
      11. TABLE 10 GLOBAL NERVE REGENERATION MARKET FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY REGION, 2023–2030 (USD MILLION) 40
      12. TABLE 11 GLOBAL NERVE REGENERATION MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY REGION, 2023–2030 (USD MILLION) 41
      13. TABLE 12 GLOBAL NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 42
      14. TABLE 13 GLOBAL NERVE REGENERATION MARKET FOR NERVE GRAFTING, BY REGION, 2023–2030 (USD MILLION) 42
      15. TABLE 14 GLOBAL NERVE REGENERATION MARKET FOR STEM CELL THERAPY, BY REGION, 2023–2030 (USD MILLION) 43
      16. TABLE 15 GLOBAL NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 44
      17. TABLE 16 GLOBAL NERVE REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION) 45
      18. TABLE 17 GLOBAL NERVE REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 46
      19. TABLE 18 GLOBAL NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 47
      20. TABLE 19 AMERICAS: NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 48
      21. TABLE 20 AMERICAS: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 49
      22. TABLE 21 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 49
      23. TABLE 22 AMERICAS: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 50
      24. TABLE 23 AMERICAS: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 50
      25. TABLE 24 AMERICAS: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 51
      26. TABLE 25 AMERICAS: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 51
      27. TABLE 26 AMERICAS: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 52
      28. TABLE 27 AMERICAS: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 52
      29. TABLE 28 AMERICAS: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 53
      30. TABLE 29 NORTH AMERICA: NERVE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 53
      31. TABLE 30 NORTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 54
      32. TABLE 31 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 54
      33. TABLE 32 NORTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 55
      34. TABLE 33 NORTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 55
      35. TABLE 34 NORTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 56
      36. TABLE 35 NORTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 56
      37. TABLE 36 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 57
      38. TABLE 37 NORTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 57
      39. TABLE 38 NORTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 58
      40. TABLE 39 US: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 58
      41. TABLE 40 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 59
      42. TABLE 41 US: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 59
      43. TABLE 42 US: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 60
      44. TABLE 43 US: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 60
      45. TABLE 44 US: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 61
      46. TABLE 45 US: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 61
      47. TABLE 46 US: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 62
      48. TABLE 47 US: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 62
      49. TABLE 48 CANADA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 63
      50. TABLE 49 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 63
      51. TABLE 50 CANADA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 64
      52. TABLE 51 CANADA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 64
      53. TABLE 52 CANADA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 65
      54. TABLE 53 CANADA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 65
      55. TABLE 54 CANADA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 66
      56. TABLE 55 CANADA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 66
      57. TABLE 56 CANADA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 67
      58. TABLE 57 SOUTH AMERICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 67
      59. TABLE 58 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 68
      60. TABLE 59 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 68
      61. TABLE 60 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 69
      62. TABLE 61 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 69
      63. TABLE 62 SOUTH AMERICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 70
      64. TABLE 63 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 70
      65. TABLE 64 SOUTH AMERICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 71
      66. TABLE 65 SOUTH AMERICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 71
      67. TABLE 66 EUROPE: NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 72
      68. TABLE 67 EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 73
      69. TABLE 68 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 73
      70. TABLE 69 EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 74
      71. TABLE 70 EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 74
      72. TABLE 71 EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 75
      73. TABLE 72 EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 75
      74. TABLE 73 EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 76
      75. TABLE 74 EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 76
      76. TABLE 75 EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 77
      77. TABLE 76 WESTERN EUROPE: NERVE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 77
      78. TABLE 77 WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 78
      79. TABLE 78 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 78
      80. TABLE 79 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 79
      81. TABLE 80 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 79
      82. TABLE 81 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 80
      83. TABLE 82 WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 80
      84. TABLE 83 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 81
      85. TABLE 84 WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 81
      86. TABLE 85 WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 82
      87. TABLE 86 GERMANY: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 82
      88. TABLE 87 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 83
      89. TABLE 88 GERMANY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 83
      90. TABLE 89 GERMANY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 84
      91. TABLE 90 GERMANY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 84
      92. TABLE 91 GERMANY: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 85
      93. TABLE 92 GERMANY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 85
      94. TABLE 93 GERMANY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 86
      95. TABLE 94 GERMANY: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 86
      96. TABLE 95 FRANCE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 87
      97. TABLE 96 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 87
      98. TABLE 97 FRANCE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 88
      99. TABLE 98 FRANCE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 88
      100. TABLE 99 FRANCE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 89
      101. TABLE 100 FRANCE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 89
      102. TABLE 101 FRANCE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 90
      103. TABLE 102 FRANCE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 90
      104. TABLE 103 FRANCE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 91
      105. TABLE 104 ITALY: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 91
      106. TABLE 105 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 92
      107. TABLE 106 ITALY: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 92
      108. TABLE 107 ITALY: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 93
      109. TABLE 108 ITALY: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 93
      110. TABLE 109 ITALY: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 94
      111. TABLE 110 ITALY: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 94
      112. TABLE 111 ITALY: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 95
      113. TABLE 112 ITALY: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 95
      114. TABLE 113 SPAIN: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 96
      115. TABLE 114 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 96
      116. TABLE 115 SPAIN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 97
      117. TABLE 116 SPAIN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 97
      118. TABLE 117 SPAIN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 98
      119. TABLE 118 SPAIN: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 98
      120. TABLE 119 SPAIN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 99
      121. TABLE 120 SPAIN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 99
      122. TABLE 121 SPAIN: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 100
      123. TABLE 122 UK: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 100
      124. TABLE 123 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 101
      125. TABLE 124 UK: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 101
      126. TABLE 125 UK: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 102
      127. TABLE 126 UK: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 102
      128. TABLE 127 UK: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 103
      129. TABLE 128 UK: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 103
      130. TABLE 129 UK: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 104
      131. TABLE 130 UK: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 104
      132. TABLE 131 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 105
      133. TABLE 132 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 105
      134. TABLE 133 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 106
      135. TABLE 134 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 106
      136. TABLE 135 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 107
      137. TABLE 136 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 107
      138. TABLE 137 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 108
      139. TABLE 138 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 108
      140. TABLE 139 REST OF WESTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 109
      141. TABLE 140 EASTERN EUROPE: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 109
      142. TABLE 141 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 110
      143. TABLE 142 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 110
      144. TABLE 143 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 111
      145. TABLE 144 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 111
      146. TABLE 145 EASTERN EUROPE: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 112
      147. TABLE 146 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 112
      148. TABLE 147 EASTERN EUROPE: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 113
      149. TABLE 148 EASTERN EUROPE: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 113
      150. TABLE 149 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114
      151. TABLE 150 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 115
      152. TABLE 151 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 115
      153. TABLE 152 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 116
      154. TABLE 153 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 116
      155. TABLE 154 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 117
      156. TABLE 155 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 117
      157. TABLE 156 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 118
      158. TABLE 157 ASIA–PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 118
      159. TABLE 158 ASIA–PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 119
      160. TABLE 159 CHINA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 119
      161. TABLE 160 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 120
      162. TABLE 161 CHINA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 120
      163. TABLE 162 CHINA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 121
      164. TABLE 163 CHINA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 121
      165. TABLE 164 CHINA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 122
      166. TABLE 165 CHINA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 122
      167. TABLE 166 CHINA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 123
      168. TABLE 167 CHINA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 123
      169. TABLE 168 JAPAN: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 124
      170. TABLE 169 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 124
      171. TABLE 170 JAPAN: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 125
      172. TABLE 171 JAPAN: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 125
      173. TABLE 172 JAPAN: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 126
      174. TABLE 173 JAPAN: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 126
      175. TABLE 174 JAPAN: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 127
      176. TABLE 175 JAPAN: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 127
      177. TABLE 176 JAPAN: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 128
      178. TABLE 177 INDIA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 128
      179. TABLE 178 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 129
      180. TABLE 179 INDIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 129
      181. TABLE 180 INDIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 130
      182. TABLE 181 INDIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 130
      183. TABLE 182 INDIA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131
      184. TABLE 183 INDIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 131
      185. TABLE 184 INDIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 132
      186. TABLE 185 INDIA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 132
      187. TABLE 186 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 133
      188. TABLE 187 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 133
      189. TABLE 188 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 134
      190. TABLE 189 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 134
      191. TABLE 190 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 135
      192. TABLE 191 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 135
      193. TABLE 192 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 136
      194. TABLE 193 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 136
      195. TABLE 194 REPUBLIC OF KOREA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 137
      196. TABLE 195 AUSTRALIA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 137
      197. TABLE 196 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 138
      198. TABLE 197 AUSTRALIA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 138
      199. TABLE 198 AUSTRALIA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 139
      200. TABLE 199 AUSTRALIA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 139
      201. TABLE 200 AUSTRALIA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 140
      202. TABLE 201 AUSTRALIA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 140
      203. TABLE 202 AUSTRALIA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 141
      204. TABLE 203 AUSTRALIA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 141
      205. TABLE 204 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 142
      206. TABLE 205 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 142
      207. TABLE 206 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 143
      208. TABLE 207 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 143
      209. TABLE 208 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 144
      210. TABLE 209 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 144
      211. TABLE 210 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 145
      212. TABLE 211 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 145
      213. TABLE 212 REST OF ASIA PACIFIC: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 146
      214. TABLE 213 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY REGION, 2023–2030 (USD MILLION) 147
      215. TABLE 214 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148
      216. TABLE 215 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 148
      217. TABLE 216 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 149
      218. TABLE 217 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 149
      219. TABLE 218 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR BIOMATERIALS, BY TYPE, 2023–2030 (USD MILLION) 150
      220. TABLE 219 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 150
      221. TABLE 220 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2023–2030 (USD MILLION) 151
      222. TABLE 221 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, FOR NERVE GRAFTING, BY TYPE, 2023–2030 (USD MILLION) 151
      223. TABLE 222 MIDDLE EAST & AFRICA: NERVE REGENERATION MARKET, BY END USER, 2023–2030 (USD MILLION) 152
      224. TABLE 223 MIDDLE EAST: NERVE REGENERATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152
      225. TABLE 224 MIDDLE EAST: NERVE REGENERATION MARKET, FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 153
      226. TABLE 225 MIDDLE EAST: NERVE REGENERATION MARKET, FOR INTERNAL NEUROSTIMULATION DEVICES, BY TYPE, 2023–2030 (USD MILLION) 153
      227. TABLE 226 MIDDLE EAST: NERVE REGENERATION MARKET, FOR EXTERNAL NEUROSTIMULATI

    Nerve Regeneration Market Segmentation

    Nerve Regeneration Product Outlook (USD Billion, 2018-2030)

    • Neurostimulation & Neuromodulation Devices
    • Biomaterials

    Nerve Regeneration Application Outlook (USD Billion, 2018-2030)

    • Neurostimulation and Neuromodulation Surgeries
    • Direct Nerve Repair/Neurorrhaphy
    • Nerve Grafting
    • Stem Cell Therapy

    Nerve Regeneration End User Outlook (USD Billion, 2018-2030)

    • Hospitals & Clinics
    • Ambulatory Surgery Centers

    Nerve Regeneration Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)

      • North America Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • North America Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • North America Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • US Outlook (USD Billion, 2018-2030)

      • US Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • US Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • US Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • CANADA Outlook (USD Billion, 2018-2030)

      • CANADA Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • CANADA Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • CANADA Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

    • Europe Outlook (USD Billion, 2018-2030)

      • Europe Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Europe Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Europe Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Germany Outlook (USD Billion, 2018-2030)

      • Germany Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Germany Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Germany Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • France Outlook (USD Billion, 2018-2030)

      • France Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • France Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • France Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • UK Outlook (USD Billion, 2018-2030)

      • UK Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • UK Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy Nerve Grafting
        • Stem Cell Therapy
      • UK Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • ITALY Outlook (USD Billion, 2018-2030)

      • ITALY Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • ITALY Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • ITALY Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • SPAIN Outlook (USD Billion, 2018-2030)

      • Spain Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Spain Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Spain Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Rest Of Europe Outlook (USD Billion, 2018-2030)

      • Rest Of Europe Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • REST OF EUROPE Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • REST OF EUROPE Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

    • Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Asia-Pacific Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Asia-Pacific Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Asia-Pacific Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • China Outlook (USD Billion, 2018-2030)

      • China Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • China Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • China Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Japan Outlook (USD Billion, 2018-2030)

      • Japan Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Japan Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Japan Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • India Outlook (USD Billion, 2018-2030)

      • India Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • India Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • India Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Australia Outlook (USD Billion, 2018-2030)

      • Australia Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Australia Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Australia Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

      • Rest of Asia-Pacific Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Rest of Asia-Pacific Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Rest of Asia-Pacific Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

    • Rest of the World Outlook (USD Billion, 2018-2030)

      • Rest of the World Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Rest of the World Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Rest of the World Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Middle East Outlook (USD Billion, 2018-2030)

      • Middle East Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Middle East Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Middle East Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Africa Outlook (USD Billion, 2018-2030)

      • Africa Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Africa Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Africa Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

      • Latin America Outlook (USD Billion, 2018-2030)

      • Latin America Nerve Regeneration by Product
        • Neurostimulation & Neuromodulation Devices
        • Biomaterials
      • Latin America Nerve Regeneration by Application
        • Neurostimulation and Neuromodulation Surgeries
        • Direct Nerve Repair/Neurorrhaphy
        • Nerve Grafting
        • Stem Cell Therapy
      • Latin America Nerve Regeneration by End User
        • Hospitals & Clinics
        • Ambulatory Surgery Centers

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027